These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24909066)

  • 21. Editorial comment.
    Epstein JI
    J Urol; 2010 Mar; 183(3):1001. PubMed ID: 20089268
    [No Abstract]   [Full Text] [Related]  

  • 22. Editorial comment.
    Vollmer RT
    J Urol; 2010 Mar; 183(3):1001-2. PubMed ID: 20089267
    [No Abstract]   [Full Text] [Related]  

  • 23. Can prostate specific antigen derivatives reduce the frequency of unnecessary prostate biopsies?
    Klein EA
    J Urol; 1996 Aug; 156(2 Pt 1):443-4. PubMed ID: 8683698
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial Comment to Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination.
    Goris Gbenou MC
    Int J Urol; 2014 Mar; 21(3):262-3. PubMed ID: 24015755
    [No Abstract]   [Full Text] [Related]  

  • 25. Editorial comment on: reassessing the diagnostic yield of saturation biopsy of the prostate.
    Philip J
    Eur Urol; 2008 May; 53(5):981-2. PubMed ID: 17997013
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: Lessons learned from prostate biopsies.
    McCullough DL
    J Urol; 2002 Nov; 168(5):2000. PubMed ID: 12394694
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial comment on: reassessing the diagnostic yield of saturation biopsy of the prostate.
    Patel A
    Eur Urol; 2008 May; 53(5):982-3. PubMed ID: 17997023
    [No Abstract]   [Full Text] [Related]  

  • 28. Association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy.
    Moreira DM; Gerber L; Thomas JA; Bañez LL; McKeever MG; Freedland SJ
    Int J Urol; 2012 Aug; 19(8):741-7. PubMed ID: 22487442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial comment on: preliminary results of a novel method to estimate the probability of prostate cancer in men with elevated serum PSA values.
    Chun FK; Briganti A
    Eur Urol; 2008 Sep; 54(3):702. PubMed ID: 18403097
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Kryvenko et al.: Prostate-specific Antigen Mass Density - A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution (Urology, 2016;90:141-147).
    Pishgar F
    Urology; 2016 Apr; 90():228-9. PubMed ID: 26809070
    [No Abstract]   [Full Text] [Related]  

  • 31. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA.
    Stamey TA
    BJU Int; 2004 Nov; 94(7):963-4. PubMed ID: 15541106
    [No Abstract]   [Full Text] [Related]  

  • 33. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
    BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editorial comment on: diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter.
    Froehner M
    Eur Urol; 2008 Aug; 54(2):368-9. PubMed ID: 18006213
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial comment on: diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter.
    Stephan C; Jung K
    Eur Urol; 2008 Aug; 54(2):369-70. PubMed ID: 18006212
    [No Abstract]   [Full Text] [Related]  

  • 36. Biopsies for "normal" PSA? Certain relatively young, healthy men with PSA levels below 4 should consider having a biopsy.
    Gerber GS
    Health News; 2004 Jul; 10(7):4-5. PubMed ID: 15239153
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial comment on: prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.
    Malavaud B
    Eur Urol; 2008 Sep; 54(3):515-6. PubMed ID: 18585850
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of rising prostate-specific antigen following a negative biopsy.
    Jones JS
    Curr Opin Urol; 2010 May; 20(3):198-203. PubMed ID: 20583345
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comment on Grond, A., M. Ostermann-Myrau: Benign and malignant diseases of the prostate].
    Grond A
    Versicherungsmedizin; 1995 Apr; 47(2):66-7. PubMed ID: 7539193
    [No Abstract]   [Full Text] [Related]  

  • 40. Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006.
    Stamatiou K; Alevizos A; Mariolis A; Sofras F
    J Urol; 2006 Sep; 176(3):1251-2; author reply 1252. PubMed ID: 16890735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.